BioCentury
ARTICLE | Company News

DUSA, Noven deal

February 7, 1994 8:00 AM UTC

NOVN (Miami) will develop a transdermal delivery system to treat basal cell carcinoma using 5-Aminolevulinic Acid (ALA), a compound developed by DUSA (Denville, N.J.) for use in photodynamic therapy. ...